Krishna Institute of Medical Sciences Ltd.
-
NSE: KIMS
-
BSE: 543308
-
Q
-
V
-
T
Quality Score
Medium Financial StrengthValuation Score
Expensive ValuationTechnical Score
Technically Moderately BullishBroker average target upside %
10.40 %
Below industry Median
TTM PE Ratio
38.00
Below industry Median
Price to Book Ratio
6.60
Above industry Median
Operating Revenues Qtr Cr
575.90 Cr
Above industry Median
Net Profit Qtr Cr
93.30 Cr
Above industry Median
RSI
63.80
RSI is mid-range
MFI
24.00
MFI oversold
MACD
36.60
MACD above Signal and Center
MACD Signal Line
34.30
MACD above Signal and Center
30Day SMA Rs
1534.90 Rs
Price above SMA 1534.87
50Day SMA Rs
1482.10 Rs
Price above SMA 1482.07
100Day SMA Rs
1457.90 Rs
Price above SMA 1457.88
200Day SMA Rs
1433.90 Rs
Price above SMA 1433.92
Promoter holding %
38.84
No change in Promoter holding
FII holding current Qtr %
19.41
FII holdings fell by 1.09%
MF holding current Qtr %
21.68
MF holdings rise by 1.28%
Institutions holding %
49.17
Institutions holding increased by 0.3500%.
Broker Average Rating
5.00
Broker Average Rating
Broker Covering stock
4.00
4 Broker Covering stock
Broker 1Year total
17.00
17 Broker 1Year total
Broker 6M Reco downgrade
0.00
0 Broker 6M Reco downgrade
Broker 6M Reco upgrade
0.00
0 Broker 6M Reco upgrade
Broker 6M Target downgrade
1.00
1 Broker 6M Target downgrade
Broker 6M Target upgrade
2.00
2 Broker 6M Target upgrade
Momentum score
68.09
Technically Moderately Bullish
Valuation score
18.67
Expensive Valuation
Quality score
46.39
Medium Financial Strength
-
- 2023-05-31T05:08:23+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for General Atantic Singapore KH Pte Ltd
Read More -
- 2023-05-27T07:16:17+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended 31st March, 2023.
Read More -
- 2023-05-25T07:15:58+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
the Company organized a conference call with the Investors/ Analysts on Friday, 19th May 2023 at 11:00 AM (IST). A copy of the Transcript of the conference call held with the Investors/ Analysts is enclosed herewith and the same has also been uploaded on the Company''s Website
Read More -
- 2023-05-19T10:57:03+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed a copy of the newspaper publication of the audited (Standalone and Consolidated) financial results of the company for the Quarter and Year ended 31st March 2023 published on 19th May 2023 in Financial Express (English) and Navatelangana (Telugu).
Read More -
- 2023-05-19T10:46:38+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Mr. Vikas Maheshwari, Chief Financial Officer and Key Managerial Personnel of the Company has tendered his resignation due to personal reasons. The Board accepted his resignation and he will be relieved from his duties with effect from the closure of business hours on May 31, 2023
Read More -
- 2023-05-19T10:08:14+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
The conference call for Q4 FY23 Results was hosted on May 19, 2023 and the web link for the audio recording of the conference call, is available on the Company's website at https://www.kimshospitals.com/investors > Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015 > Analysts Calls schedule, PPT & Transcripts > Transcripts, Audio & Video Recordings > FY 22-23
Read More -
- 2023-05-19T07:30:37+00:00
Krishna Institute of Medical Sciences Results Earnings Call for Q4FY23
Conference Call with Krishna Institute of Medical Sciences Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.
Read More -
- 2023-05-18T17:51:58+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Compliance Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
With reference to the captioned subject matter, please find enclosed herewith the Related Parties Transactions of the Company for the Half Year ended March 31, 2023.
Read More -
- 2023-05-18T14:08:33+00:00
Q4FY23 Quarterly Result Announced for Krishna Institute of Medical Sciences Ltd.
Healthcare Facilities company Krishna Institute of Medical Sciences announced Q4FY23 results: Consolidated Q4FY23: Revenue from operations grew by 54.7% YoY basis and 2.4% on QoQ basis to Rs 5,759.2 million EBITDA (Pre-INDAS and Other Income) grew by 38.8% on a YoY basis and 8.3% on a QoQ basis to Rs 1,563.3 million EBITDA Margin stands at 27.1% which has improved by 1.4% over the previous quarter; led by operational efficiency PAT grew by 18.4% on a YoY basis and 20.6% on a QoQ basis to Rs 986 million EPS grew by 15.6% on a YoY basis and 22.8% on a QoQ basis to Rs 11.7 Commenting on the performance, Dr. B. Bhaskara Rao, Chairman & Managing Director said: “The last quarter of FY23 saw us deliver our best-ever Quarterly numbers It is a testimony to the continued trust of patients in KIMS’s quality of service, and clinical excellence, and delivering the same with affordability. We continue to focus on identifying experienced clinical talents across specialties and geographies and adding new therapies which will help us drive growth in the coming quarters Our digital automation project to deliver an even better patient experience is progressing at a brisk pace. I am confident we will keep the momentum going in FY24 to deliver patient satisfaction and financial growth together.” Result PDF
Read More -
- 2023-05-18T13:35:44+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - The 21St Annual General Meeting Of The Company Will Be Held On Wednesday, 30Th August 2023.
The 21st Annual General Meeting of the Company will be held on Wednesday, 30th August 2023.
Read More -
- 2023-05-18T13:17:13+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith the Investor Presentation on Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended 31st March 2023.
Read More -
- 2023-05-18T13:10:52+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the above-stated subject, please find enclosed herewith the Press Release on the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended 31st March 2023.
Read More -
- 2023-05-18T12:48:00+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Approval Of Audited (Standalone & Consolidated) Financial Results For The Quarter And Year Ended 31St March 2023
Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have approved the Audited Standalone and Consolidated Financial Results of the Company along with the Auditor's Report for the Quarter and Year ended 31st March 2023 issued by M/s. S.R. Batliboi & Associates LLP, the Statutory Auditors of the Company which are enclosed to this letter.
Read More -
- 2023-05-18T12:44:43+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Outcome for Outcome Of Board Meeting Held On 18Th May 2023 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
1. Approval of Audited standalone & Consolidated financial results of the Company for the quarter and year ended 31st March 2023, along with the Audit Report on the Standalone & Consolidated Financial Statements. 2. Resignation of CFO
Read More -
- 2023-05-17T13:33:30+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation about conference call for analysts and investors
Read More -
- 2023-05-11T05:49:41+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Intimation for To Consider And Approve The Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2023.
Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2023 ,inter alia, to consider and approve the Audited (Standalone & Consolidated) Financial results of the company for the quarter and financial year ended March 31, 2023.
Read More -
- 2023-04-25T11:36:22+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKrishna Institute of Medical Sciences Ltd 2CIN NO.L55101TG1973PLC040558 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 4.17 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Umashankar Mantha Designation: Company Secretary and Compliance Officer EmailId: cs@kimshospitals.com Name of the Chief Financial Officer: Vikas Maheshwari Designation: CFO EmailId: Vikas@kimshospitals.com Date: 25/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Read More -
- 2023-04-24T10:26:48+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015
Please find enclosed the Certificate under Regulation 40(9) of SEBI (LODR) Regulations 2015, issued by the Practicing Company Secretary for the year ended March 31. 2023.
Read More -
- 2023-04-12T12:24:50+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Compliance Certificate For The Period Ended 31St March, 2023
As per the requirement of Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that all activities in relation to both physical and electronic share transfer facility during the period April 01, 2022 to March 31, 2023 (both days inclusive) are maintained by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Pvt. Ltd a Category-I, Registrar & Share Transfer Agent (RTA), registered with the Securities and Exchange Board of India (SEBI) vide Registration Number: INR000004058..
Read More -
- 2023-04-12T11:30:40+00:00
Krishna Institute of Medical Sciences Ltd - 543308 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2023.
Read More
| Ex-date | Dividend Amount | Dividend Type | Record Date |
|---|
Bonus History
Adani Ports & Special Economic Zone Ltd. has not announced any bonus since Jan 1, 2000.
Check out stocks with top dividendAdani Ports & Special Economic Zone Ltd. has split the face value 1 time since Sept. 23, 2010. Adani Ports & Special Economic Zone Ltd. had last split the face value of its shares from Rs 10 to Rs 2 in 2016.The share has been quoting on an ex-split basis from Sept. 23, 2010.
| Ex-date | Old FV | New FV | Record Date |
|---|---|---|---|
| Sept. 23, 2010 | 10 | FINAL | Sept. 24, 2010 |